Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7601607rdf:typepubmed:Citationlld:pubmed
pubmed-article:7601607lifeskim:mentionsumls-concept:C0030956lld:lifeskim
pubmed-article:7601607lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:7601607lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:7601607lifeskim:mentionsumls-concept:C1136254lld:lifeskim
pubmed-article:7601607lifeskim:mentionsumls-concept:C1707689lld:lifeskim
pubmed-article:7601607pubmed:issue4lld:pubmed
pubmed-article:7601607pubmed:dateCreated1995-8-7lld:pubmed
pubmed-article:7601607pubmed:abstractTextA large proportion of antimicrobial peptides share a common structural feature that is critical to their antimicrobial activity, i.e. amphipathic alpha-helices. The amphipathy of a polypeptide chain can be quantitated through the value of the hydrophobic moment. Generally, antimicrobial peptides are characterized by high hydrophobic moment and low hydrophobicity values. Using these criteria we have identified two short segments that possess hydrophobic moment properties associated with known antimicrobial peptides. Using in vitro assays the segment derived from the protein perforin displays no antifungal or antibacterial activity and, while showing no alpha-helicity in buffer or liposomes, exhibits a modest degree of alpha-helical structure in the presence of the alpha-helical inducer, 2,2,2-trifluoroethanol. However, rational modifications result in a derivative which assumes an alpha-helical conformation in the presence of liposomes, exhibits potent antifungal activity against plant fungal pathogens, has significant antibacterial activity, effects leakage of a fluorescent dye from acidic liposomes and is devoid of hemolytic activity. Results are also presented for a segment derived from the human immunodeficiency virus envelope protein. We suggest that the identification of putative amphipathic structures in proteins may provide a useful starting strategy in the design and synthesis of antimicrobial peptides.lld:pubmed
pubmed-article:7601607pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7601607pubmed:languageenglld:pubmed
pubmed-article:7601607pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7601607pubmed:citationSubsetIMlld:pubmed
pubmed-article:7601607pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7601607pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7601607pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7601607pubmed:statusMEDLINElld:pubmed
pubmed-article:7601607pubmed:monthAprlld:pubmed
pubmed-article:7601607pubmed:issn0367-8377lld:pubmed
pubmed-article:7601607pubmed:authorpubmed-author:JohnsonW...lld:pubmed
pubmed-article:7601607pubmed:authorpubmed-author:RayA AAAlld:pubmed
pubmed-article:7601607pubmed:authorpubmed-author:ZhongLLlld:pubmed
pubmed-article:7601607pubmed:authorpubmed-author:PutnamR JRJlld:pubmed
pubmed-article:7601607pubmed:issnTypePrintlld:pubmed
pubmed-article:7601607pubmed:volume45lld:pubmed
pubmed-article:7601607pubmed:ownerNLMlld:pubmed
pubmed-article:7601607pubmed:authorsCompleteYlld:pubmed
pubmed-article:7601607pubmed:pagination337-47lld:pubmed
pubmed-article:7601607pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:7601607pubmed:meshHeadingpubmed-meshheading:7601607-...lld:pubmed
pubmed-article:7601607pubmed:meshHeadingpubmed-meshheading:7601607-...lld:pubmed
pubmed-article:7601607pubmed:meshHeadingpubmed-meshheading:7601607-...lld:pubmed
pubmed-article:7601607pubmed:meshHeadingpubmed-meshheading:7601607-...lld:pubmed
pubmed-article:7601607pubmed:meshHeadingpubmed-meshheading:7601607-...lld:pubmed
pubmed-article:7601607pubmed:meshHeadingpubmed-meshheading:7601607-...lld:pubmed
pubmed-article:7601607pubmed:meshHeadingpubmed-meshheading:7601607-...lld:pubmed
pubmed-article:7601607pubmed:meshHeadingpubmed-meshheading:7601607-...lld:pubmed
pubmed-article:7601607pubmed:meshHeadingpubmed-meshheading:7601607-...lld:pubmed
pubmed-article:7601607pubmed:meshHeadingpubmed-meshheading:7601607-...lld:pubmed
pubmed-article:7601607pubmed:meshHeadingpubmed-meshheading:7601607-...lld:pubmed
pubmed-article:7601607pubmed:meshHeadingpubmed-meshheading:7601607-...lld:pubmed
pubmed-article:7601607pubmed:meshHeadingpubmed-meshheading:7601607-...lld:pubmed
pubmed-article:7601607pubmed:year1995lld:pubmed
pubmed-article:7601607pubmed:articleTitleDesign and synthesis of amphipathic antimicrobial peptides.lld:pubmed
pubmed-article:7601607pubmed:affiliationDepartment of Traits and Technology Development, Pioneer Hi-Bred International, Inc., Johnston, Iowa, USA.lld:pubmed
pubmed-article:7601607pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7601607pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7601607lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7601607lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7601607lld:pubmed